DAX1/NR0B1 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-68781
Key Product Details
Species Reactivity
Human
Applications
Immunocytochemistry/ Immunofluorescence
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
This antibody was developed against a recombinant protein corresponding to amino acids: GKDHPRQGSILYSMLTSAKQTYAAPKAPEATLGPCWGCSCGSDPGVGRAGLPGGRPVALLYRCCF
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for DAX1/NR0B1 Antibody
Immunocytochemistry/ Immunofluorescence: DAX1/NR0B1 Antibody [NBP2-68781]
Immunocytochemistry/Immunofluorescence: DAX1/NR0B1 Antibody [NBP2-68781] - Staining of human cell line A549 shows localization to nuclear speckles & vesicles.Applications for DAX1/NR0B1 Antibody
Application
Recommended Usage
Immunocytochemistry/ Immunofluorescence
0.25-2 ug/ml
Application Notes
Recommended conditions:
Fixation/Permeabilization: PFA/Triton X-100
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS (pH 7.2) and 40% Glycerol
Preservative
0.02% Sodium Azide
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: DAX1/NR0B1
Long Name
Orphan Nuclear Receptor DAX1/Nuclear Receptor Subfamily 0, Group B, Member 1
Alternate Names
AHC, AHCH, NR0B1
Gene Symbol
NR0B1
Additional DAX1/NR0B1 Products
Product Documents for DAX1/NR0B1 Antibody
Product Specific Notices for DAX1/NR0B1 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...